University of California San Francisco Dept of Oncology
Welcome,         Profile    Billing    Logout  
 2 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ryan, Charles
NCT03016741: Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Recruiting
4
100
US
GnRH agonist/antagonist, Prednisone, Abiraterone Acetate, Zytiga, Enzalutamide, Xtandi
Northwestern University
Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer, Hormone-Refractory Prostate Cancer
08/22
08/23
ARACOG, NCT04335682: Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide

Recruiting
2
132
US
Darolutamide, Nubeqa, Enzalutamide, Xtandi
Alliance Foundation Trials, LLC., Bayer
Metastatic Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer, Castrate Resistant Prostate Cancer, Hormone Sensitive Prostate Cancer, Non-metastatic Prostate Cancer
08/25
08/26
NCT05705700: Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)

Withdrawn
2
140
NA
Dutasteride, Abiraterone
Masonic Cancer Center, University of Minnesota
Prostate Cancer
01/30
01/30
INTERVAL, NCT02730338: INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer ( - GAP4)

Active, not recruiting
N/A
866
Europe, Canada, US, RoW
High intensity aerobic and resistance training, Psychosocial support
Movember Foundation, University of California, San Francisco, Edith Cowan University, King's College London, Centre hospitalier de l'Université de Montréal (CHUM)
Metastatic Prostate Cancer
10/25
10/26
Reinert, Anne
No trials found

Download Options